Finger-Prick test at home boosts virus monitoring in transplant patients

NCT ID NCT03910478

Completed Knowledge-focused Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether having patients collect a small blood sample at home (using a finger prick) and getting reminders on their phone could help them stick to weekly testing for cytomegalovirus (CMV) after a stem cell transplant. About 150 transplant recipients took part. The goal was to see if this approach improved how many recommended tests were completed compared to standard care. The findings could make monitoring easier and more convenient for patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CYTOMEGALOVIRUS INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cytomegalovirus infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CYTOMEGALOVIRUS INFECTION

Contacts and locations

Locations

Fred Hutchinson Cancer Research Center - Vaccine and Infectious Diseases

Seattle, Washington, 98109-4433, United States
Memorial Sloan Kettering Cancer Center

New York, New York, 10065-6007, United States
The University of Texas - MD Anderson Cancer Center - Infectious Diseases

Houston, Texas, 77030-4000, United States
University of Minnesota Medical Center, Fairview - Infectious Diseases and International Medicine

Minneapolis, Minnesota, 55455-0356, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.